32
Views
9
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

First Report of a Novel Extended-Spectrum Beta-Lactamase KOXY-2 Producing Klebsiella oxytoca that Hydrolyses Cefotaxime and Ceftazidime

Pages 127-130 | Published online: 18 Jul 2013

REFERENCES

  • Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11 (4): 589–603.
  • Fevre C, Jbel M, Passet V, Weill FX, Grimont PA, Brisse S. Six groups of the OXY beta-Lactamase evolved over millions of years in Klebsiella oxy-toca. Antimicrob Agents Chemother 2005; 49 (8): 3453–62.
  • Granier SA, Leflon-Guibout V, Nicolas-Chanoine MH, Bush K, Gold-stein FW. The extended-spectrum K1 beta-lactamase from Klebsiella oxy-toca SC 10,436 is a member of the bIa0,2 family of chromosomal Klebsiella enzymes. Antimicrob Agents Chemother 2002; 46 (6): 2056–7.
  • Arakawa Y, Ohta M, Kido N, Mori M, Ito H, Komatsu T, et al. Chro-mosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother 1989; 33 (1): 63–70.
  • Livermore DM. Beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8 (4): 557–84.
  • Fournier B, Roy PH. Variability of chromosomally encoded beta-lacta-mases from Klebsiella oxytoca. Antimicrob Agents Chemother 1997; 41 (8): 1641–8.
  • Wu SW, Dornbusch K, Kronvall G. Genetic characterization of resist-ance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates re-covered from patients with septicemia at hospitals in the Stockholm area. Antimicrob Agents Chemother 1999; 43 (5): 1294–7.
  • Fournier B, Lu CY, Lagrange PH, Krishnamoorthy R, Philippon A. Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother 1995; 39 (6): 1365–8.
  • Fournier B, Arlet G, Lagrange PH, Philippon A. Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase. FEMS Microbiol Lett 1994; 116 (1): 31–6.
  • Mammeri H, Poiret L, Nordmann P. In vivo selection of a chromoso-mally encoded beta-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca. Antimicrob Agents Chemother 2003; 47 (12): 3739–42.
  • Foumier B, Roy PH, Lagrange PH, Philippon A. Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blao, , and blao„, 2. Antimicrob Agents Chemother 1996; 40 (2): 454-9.
  • Granier SA, Leflon-Guibout V, Goldstein FW, Nicolas-Chanoine MH. New Klebsiella oxytoca beta-lactamase genes blaoxy_, and blao and a third genetic group of K oxytoca based on blaoxy„. Antimicro,b Agents Chemother 2003; 47 (9): 2922–8.
  • Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39 (6): 1211–33.
  • Ambler RP, Coulson AF, Frere JM, Ghuysen JM, Joris B, Forsman M et al. A standard numbering scheme for the class A beta-lactamases. Biochem J 1991; 276 (Pt 1): 269–70.
  • Brisse S, van Himbergen T, Kusters K, Verhoef J. Development of a rapid identification method for Klebsiella pneumoniae phylogenetic groups and analysis of 420 clinical isolates. Clin Microbiol Infect 2004; 10 (10): 942–5.
  • British Society for Antimicrobial Chemotherapy (BSAC). Methods for antimicrobial susceptibility testing. 2006; version 5.
  • Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Preva-lence and molecular epidemiology of CTX-M extended-spectrum beta-lacta-mase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003; 47 (12): 3724–32.
  • Mabilat C, Goussard S. PCR detection and identification of genes for extended-spectrum β-lactamases. In Persing DH, Smith TF, Teneover FC and White TJ. (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, DC., 1993: 553-59.
  • Mathew A, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol 1975; 88 (1): 169–178.
  • Miranda G, Kelly C, Solorzano F, Leanos B, Coria R, Patterson JE. Use of pulsed-field gel electrophoresis typing to study an outbreak of infec-tion due to Serratia marcescens in a neonatal intensive care unit. J Clin Mi-crobiol 1996; 34 (12): 3138–41.
  • Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Pers-ing DH et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33 (9): 2233–39.
  • Fournier B, Gravel A, Hooper DC, Roy PH. Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca. Antimicrob Agents Chemother 1999; 43 (4): 850–55.
  • Healey WJ, Labgold MR, Richards JH. Substrate specificities in class A beta-lactamases: preference for penams vs. cephems. The role of residue 237. Proteins 1989; 6 (3): 275-83.
  • Knox JR. Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure. An timi-crob Agents Chemother 1995; 39 (12): 2593–601.
  • Decre D, Burghoffer B, Gautier V, Petit JC, Arlet G. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum beta-lactamases and strains with extended-spectrum activity of the chromo-somal beta-lactamase. J Antimicrob Chemother 2004; 54 (5): 881–88.
  • Petit A, Sirot DL, Chanal CM, Sirot JL, Labia R, Gerbaud G et al. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneu-moniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob Agents Chemother 1988; 32 (5): 626-30.
  • Chanal CM, Sirot DL, Petit A, Labia R, Morand A, Sirot JL et al. Mul-tiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plas-mids. Antimicrob Agents Chemother 1989; 33 (11): 1915-20.
  • Baraniak A, Fiett J, Mrowka A, Walory J, Hryniewicz W, Gniadkowski M. Evolution of TEM-type extended-spectrum beta-lactamases in clinical En-terobacteriaceae strains in Poland. Antimicrob Agents Chemother 2005; 49 (5): 1872–80.
  • Kruger T, Szabo D, Keddy KH, Deeley K, Marsh JW, Hujer AM et al. Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa. Antimicrob Agents Chemother 2004; 48 (11): 4263-70.
  • Poiret L, Mammeril l, Nordmann P. TEM-121, a novel complex mu-tant of TEM-type beta-lactamase from Enterobacter aerogenes. Antimicrob Agents Chemother 2004; 48 (12): 4528-31.
  • Sirot D, Labia R, Pouedras P, Chanal-Claris C, Cerceau C, Sirot J. In-hibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxy-toca. Antimicrob Agents Chemother 1998; 42 (9): 2184–87.
  • Hansen DS, Skov R, Benedi JV, Sperling V, Kolmos HJ. Klebsiella typing: pulsed-field gel electrophoresis (PFGE) in comparison with O:K-serotyping. Clin Microbiol Infect 2002; 8 (7): 397–404.
  • Vimont S, Mnif B, Fevre C, Brisse S. Comparison of PFGE and mul-tilocus sequence typing for analysis of Klebsiella pneumoniae isolates. J Med Microbiol 2008; 57(Pt 10): 1308–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.